This is a historical report — it no longer reflects this drug's current status. Current status: Anticipated Shortage. View this drug's full profile page →
SYNTHROID
BGP PHARMA ULC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of SYNTHROID in Canada?
A shortage of SYNTHROID 75MCG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated September 22, 2026), but it has not started yet.
Why is SYNTHROID not available?
The reason the manufacturer reported: Demand increase for the drug.
When will SYNTHROID be available again?
The manufacturer's estimated resolution date is November 3, 2026. This is an estimate and can change; follow this page to get an email when the status changes.
What this means
Does this mean the shortage is completely over everywhere?
It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.
What should I do?
If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.
DIN
02172089
Strength
75MCG
Dosage Form
TABLET
Route
ORAL
Active Ingredient
LEVOTHYROXINE SODIUM
Tier
Unrated
Last Updated
2021-01-20
Reason for Shortage
Disruption of the manufacture of the drug.
Past Reports for This Drug
SYNTHROID has 2 shortage/discontinuation reports on file — this is one of them.
Other Products from BGP PHARMA ULC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.